SHARDACROP Sharda Cropchem Q3 FY26 results (Oct–Dec 2025) and concall
Sharda Cropchem delivered a robust Q3 FY26 performance, driven by strong volume growth and an improved product mix, leading to a 39% YoY revenue increase and a 366% YoY PAT surge. The company achieved its highest-ever annual PAT in 9M FY26, supported by expanded gross and EBITDA margins. While Europe showed strong growth, the NAFTA region experienced a decline, and management acknowledged uncertainties in the product registration process and pricing recovery.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 38.8%, net profit up 367.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 777 | 929 | 1,829 | 985 | 929 +20% | 1,289 +39% |
| EBITDA | 90 | 115 | 303 | 215 | 133 +48% | 241 +110% |
| Net profit | 42 | 31 | 204 | 143 | 74 +76% | 145 +368% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
